The EPO published patent application EP3675934A1 filed by Novo Nordisk A/S for a multi-use drug delivery device suitable for drugs with reduced preservative content. The application, classified under A61M (medical storage/controlled liquid transfer devices), names inventors Bengtsson, Glenting, Drustrup, and Pedersen. The designated states cover all major European patent contracting states including DE, FR, GB, IT, ES, NL, and others.

This is an informational patent publication only. Interested parties in the drug delivery or pharmaceutical manufacturing sectors should review the claims if freedom-to-operate assessments are relevant to their products. No immediate regulatory action is required. Patent protection, if granted, would not take effect until after examination and potential amendment during the 18-month prosecution period.